您的购物车当前为空
PBRM1-BD2-IN-5 是一种有效的 PBRM1 Bromodomain 抑制剂,对 PBRM1-BD2 和 PBRM1-BD5 的 Kd 分别为 1.5 μM 和 3.9 μM,对 PBRM1-BD2 的 IC50 为 0.26 μM。PBRM1-BD2-IN-5 减少细胞裂解物中 PBAF 复合体全长 PBRM1 与乙酰化组蛋白肽的结合。PBRM1-BD2-IN-5 可用于抗癌研究。


为众多的药物研发团队赋能,
让新药发现更简单!
PBRM1-BD2-IN-5 是一种有效的 PBRM1 Bromodomain 抑制剂,对 PBRM1-BD2 和 PBRM1-BD5 的 Kd 分别为 1.5 μM 和 3.9 μM,对 PBRM1-BD2 的 IC50 为 0.26 μM。PBRM1-BD2-IN-5 减少细胞裂解物中 PBAF 复合体全长 PBRM1 与乙酰化组蛋白肽的结合。PBRM1-BD2-IN-5 可用于抗癌研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 696 | In stock | |
| 2 mg | ¥ 948 | In stock | |
| 5 mg | ¥ 1,420 | In stock | |
| 10 mg | ¥ 2,110 | In stock | |
| 25 mg | ¥ 3,370 | In stock | |
| 50 mg | ¥ 4,470 | In stock | |
| 100 mg | ¥ 5,910 | In stock | |
| 500 mg | ¥ 11,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,300 | In stock |
PBRM1-BD2-IN-5 相关产品
| 产品描述 | PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, demonstrating dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5, respectively, and boasts an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2. This compound effectively diminishes the interaction between the full-length PBRM1 and acetylated histone peptide within the PBAF complex in cell lysates, which positions it as a promising candidate for anticancer research. |
| 体外活性 | PBRM1-BD2-IN-5 (compound 16) (0-10 μM; 5 days) inhibits PBRM1-expressed LNCaP cells, and reduces the binding of full-length PBRM1 within the PBAF complex in cell lysates to acetylated histone peptides[1]. |
| 分子量 | 272.73 |
| 分子式 | C15H13ClN2O |
| CAS No. | 2819989-61-0 |
| Smiles | O=C1C=2C(NC(N1)C3=CC(C)=CC=C3)=CC=CC2Cl |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (183.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.33 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容